Kerbside

Kerbside

The recommendations provided in this column are taken from various market sources such as brokers, analysts, dealers and investment strategists, etc. These recommendations may not be backed by strong fundamentals. Therefore we advise readers to use their own discretion before investing in these recommendation.

A HEALTHY CHOICE 

Aster DM Healthcare
BSE Code: 540975
CMP: Rs136.35

Aster DM Healthcare Limited is one of the largest integrated private healthcare service providers operating in GCC (Gulf Cooperation Council) countries and an emerging player in India. With an inherent emphasis on clinical excellence, the company is one of the few entities in the world with a strong presence across primary, secondary, tertiary and quaternary healthcare. Their strong network of 25 state-of-the-art hospitals, 117 clinics and 238 pharmacies helps to deliver quality healthcare at affordable rates. As per the dealer of one of the leading stock-broking agencies, the stock has seen good accumulation by HNIs in anticipation of some major development in the stock. Hence, those with high risk appetite can bet on this stock for short-medium term.

BEING FLUID AND FINE

Kirloskar Brothers
BSE Code : 500241
CMP : Rs 113.60

Kirloskar Brothers (KBL) is a world-class pump manufacturing company with expertise in engineering and manufacture of systems for fluid management. KBL is the flagship company of the USD 2.1 billion Kirloskar Group. KBL, a market leader, provides complete fluid management solutions for large infrastructure projects in the areas of water supply, power plants, irrigation, oil and gas, and marine and defence. If the gossip is to be believed the stock is likely surge in the days ahead as some big announcement is on the cards, which could help to propel the prospects of the company.

CREATING THE RIGHT FORMULA

Caplin Point Laboratories
BSE Code : 524742
CMP: Rs 394.35

Caplin Point Laboratories is a fast growing pharmaceutical company with a unique business model catering predominantly to emerging markets of Latin America and Africa. It has state-of-the-art manufacturing facilities that cater to a complete range of finished dosage forms. The company has also entered regulated markets such as US through its subsidiary, Caplin Steriles. Market gossip has it that this scrip is headed northwards on strong buying by bull operators. Those with high risk appetite can take their bets on this scrip to make some quick gains.

DESIGNED FOR SUCCESS

Tata Elxsi
BSE Code : 500408
CMP : Rs 922.65

Tata Elxsi is amongst the world’s leading providers of design and technology services across industries including automotive, broadcast, communications and healthcare. In Q1FY21, its revenue advanced by 10.7 per cent YoY and PBT increased 33.9 YoY. Revenue by segment in Q1FY21 stood as follows: embedded product design (EPD) 89.9 per cent, industrial design and visualization (IDV) 7.5 per cent and system integration and support (SIS) 2.6 per cent. Technical analysts are quite bullish on this stock and are suggesting big targets on it as the stock has seen a good breakout after a long congestion. Those willing to take some risk may buy the scrip for decent gains.

(Closing price as of July 28, 2020)

Rate this article:
No rating
Comments are only visible to subscribers.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR